Khan M S Y, Gupta M
Department of Pharmaceutical Chemistry, Hamdard University, Hamdard Nagar, New Delhi, India.
Pharmazie. 2002 Jun;57(6):377-83.
A number of potentially active hexahydropyrimidine derivatives of pharmaceutical interest have been synthesized. Various diSchiff's bases prepared by reacting different aromatic aldehydes with 1,3-diaminopropane were suitably reduced to give their tetrahydro derivatives which were then condensed with appropriate aldehydes to give a series of hitherto unreported hexahydropyrimidines. The resulting products were evaluated by oral route for their antiinflammatory activity. The activity of compounds 11, 23 and 4 was excellent and comparable to indomethacin. In addition to oral route of administration, the antiinflammatory activity of hexahydropyrimidine derivatives was also studied topically through transdermal gels. Compounds 11, 23, 4 and 22 produced significant inhibition in edema and showed good antiinflammatory activity comparable to diclofenac sodium gel (Relaxyl gel). All these compounds were also tested for their analgesic activity and their LD50 determined. Compounds 11, 20 and 23 showed a comparable activity with aspirin. The MTD for all the compounds was found to be > 1800 mg/kg.
已经合成了许多具有药学意义的潜在活性六氢嘧啶衍生物。通过使不同的芳香醛与1,3 - 二氨基丙烷反应制备的各种双席夫碱被适当地还原以得到它们的四氢衍生物,然后将这些四氢衍生物与适当的醛缩合,得到一系列迄今未报道的六氢嘧啶。通过口服途径评估所得产物的抗炎活性。化合物11、23和4的活性优异,与吲哚美辛相当。除了口服给药途径外,还通过透皮凝胶局部研究了六氢嘧啶衍生物的抗炎活性。化合物11、23、4和22对水肿产生了显著抑制作用,并表现出与双氯芬酸钠凝胶(Relaxyl凝胶)相当的良好抗炎活性。还测试了所有这些化合物的镇痛活性并测定了它们的半数致死量(LD50)。化合物11、20和23显示出与阿司匹林相当的活性。发现所有化合物的最大耐受剂量(MTD)> 1800 mg/kg。